Health
Anti-phospholipid antibodies in severely ill patients not distinctive to COVID-19, says study – News-Medical.Net
A new study by researchers at the University of Toronto and the University of Calgary in Canada indicates that the presence of these antibodies correlates with…
Recent research indicates the occurrence of thromboembolic complications involving anti-phospholipid antibodies (APLA) and the anti-phospholipid syndrome (APS) in severe coronavirus disease 2019 (COVID-19). However, conflicting reports have emerged.
A new study by researchers at the University of Toronto and the University of Calgary in Canada indicates that the presence of these antibodies correlates with more severe COVID-19 symptoms and signs.
The team have released their findings as a preprint…
-
General10 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
Noosa News24 hours agoSunshine Coast Airport receives green light for major upgrade opening doors to growth jobs and tourism across the region
-
General13 hours agoAustralia’s race to rewire the country amid a global transmission boom is not unique
-
General24 hours agoNZ government’s puberty blockers move attracts strong reactions